I148M variant in PNPLA3 reduces central adiposity and metabolic disease risks while increasing nonalcoholic fatty liver disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1478-3231|35|12|2537-2546

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.35, Iss.12, 2015-12, pp. : 2537-2546

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PNPLA3 I148M variant is associated with metabolic stress‐response phenotype in patients with nonalcoholic fatty liver disease

By  

HEPATOLOGY, Vol. 61, Iss. 5, 2015-05 ,pp. : 1769-1769

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of PNPLA3 I148M polymorphism on histologically proven non‐alcoholic fatty liver disease in liver transplant recipients

By  

HEPATOLOGY RESEARCH, Vol. 48, Iss. 3, 2018-02 ,pp. : E162-E171

John Wiley & Sons Inc

Access to resources Recommend Favorite

The common I148 M variant of PNPLA3 does not predict fibrosis progression after liver transplantation for hepatitis C

By  

HEPATOLOGY, Vol. 54, Iss. 4, 2011-10 ,pp. : 1483-1484

John Wiley & Sons Inc

Access to resources Recommend Favorite

PNPLA3 and lifestyle modification

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 1, 2015-01 ,pp. : 139-146

John Wiley & Sons Inc

Access to resources Recommend Favorite

PNPLA3 polymorphisms (rs738409) and non‐alcoholic fatty liver disease risk and related phenotypes: a meta‐analysis

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 5, 2015-05 ,pp. : 821-829

John Wiley & Sons Inc

Access to resources Recommend Favorite